FBPixel Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs - David Perlmutter M.D.

Science

Study Title
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
Publication
Rheumatology International
Author(s)

Tsvetoslav Georgiev

Abstract

The recent advances in the understanding of COVID-19 have pointed to the similarities of the cytokine storm syndromes in this viral disease and inflammatory rheumatic disorders, justifying the use of anti-rheumatic drugs in both conditions. Rheumatologists should share their experience with managing patients with rheumatic disorders and join the global multidisciplinary fight against COVID-19.

Date
March 30, 2020
View study

Share This

Related Topics

Coronavirus

Dr. David Perlmutter is on the cutting edge of innovative medicine that looks at all lifestyle influences on health and illness.

Andrew Weil, MD